Dr. Chukwuemeka Onyedika, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 154 West St Ste A, Cromwell, CT 06416 Phone: 877-373-9251 |
News Archive
A new signaling pathway, which is important for the regulation of the immune response and inflammation, was discovered by an international team of scientists led by prof Ivan Dikic from the Goethe University, Frankfurt, Germany.
A team of researchers from Brigham and Women's Hospital, Boston Medical Center and Massachusetts General Hospital has been awarded $25 million by the National Institutes of Health to conduct a four-year, randomized clinical trial-the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia). The trial will compare traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia.
A new analysis has found that many alcohol treatment studies are designed in ways that inadvertently omit women and African-Americans from participation.
BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.
Warnings of floods and rains across Queensland have sparked fears related to Ross River fever among health authorities. Ross River fever is caused by a virus carried by a number of mosquito species. It is usually associated with joint pain and swelling that can last for weeks.
› Verified 1 days ago